129 related articles for article (PubMed ID: 1992156)
1. (Acyloxy)alkyl carbamate prodrugs of norfloxacin.
Alexander J; Fromtling RA; Bland JA; Pelak BA; Gilfillan EC
J Med Chem; 1991 Jan; 34(1):78-81. PubMed ID: 1992156
[TBL] [Abstract][Full Text] [Related]
2. Studies on prodrugs. 11. Synthesis and antimicrobial activity of N-[(4-methyl-5-methylene-2-oxo-1,3-dioxolan-4-yl)oxy]norfloxacin .
Kondo H; Sakamoto F; Uno T; Kawahata Y; Tsukamoto G
J Med Chem; 1989 Mar; 32(3):671-4. PubMed ID: 2645402
[TBL] [Abstract][Full Text] [Related]
3. Studies on prodrugs. 7. Synthesis and antimicrobial activity of 3-formylquinolone derivatives.
Kondo H; Sakamoto F; Kawakami K; Tsukamoto G
J Med Chem; 1988 Jan; 31(1):221-5. PubMed ID: 3275778
[TBL] [Abstract][Full Text] [Related]
4. Diglyceride prodrug strategy for enhancing the bioavailability of norfloxacin.
Dhaneshwar S; Tewari K; Joshi S; Godbole D; Ghosh P
Chem Phys Lipids; 2011 May; 164(4):307-13. PubMed ID: 21477584
[TBL] [Abstract][Full Text] [Related]
5. Studies on prodrugs. 10. Possible mechanism of N-dealkylation of N-masked norfloxacins having several active methylene groups.
Kondo H; Sakamoto F; Inoue Y; Tsukamoto G
J Med Chem; 1989 Mar; 32(3):679-82. PubMed ID: 2918517
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation as Prodrugs of Hydrophilic Carbamate Ester Analogues of Resveratrol.
Azzolini M; Mattarei A; La Spina M; Marotta E; Zoratti M; Paradisi C; Biasutto L
Mol Pharm; 2015 Sep; 12(9):3441-54. PubMed ID: 26252229
[TBL] [Abstract][Full Text] [Related]
7. (Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes.
Alexander J; Cargill R; Michelson SR; Schwam H
J Med Chem; 1988 Feb; 31(2):318-22. PubMed ID: 2892933
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro/in vivo evaluation of novel oral N-alkyl- and N,N-dialkyl-carbamate esters of entacapone.
Savolainen J; Leppanen J; Forsberg M; Taipale H; Nevalainen T; Huuskonen J; Gynther J; Mannisto PT; Jarvinen T
Life Sci; 2000; 67(2):205-16. PubMed ID: 10901288
[TBL] [Abstract][Full Text] [Related]
9. N-Monosubstituted Methoxy-oligo(ethylene glycol) Carbamate Ester Prodrugs of Resveratrol.
Mattarei A; Azzolini M; Zoratti M; Biasutto L; Paradisi C
Molecules; 2015 Sep; 20(9):16085-102. PubMed ID: 26404221
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, degradation, and antimicrobial properties of targeted macromolecular prodrugs of norfloxacin.
Roseeuw E; Coessens V; Balazuc AM; Lagranderie M; Chavarot P; Pessina A; Neri MG; Schacht E; Marchal G; Domurado D
Antimicrob Agents Chemother; 2003 Nov; 47(11):3435-41. PubMed ID: 14576099
[TBL] [Abstract][Full Text] [Related]
11. Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics.
Li Y; Wang Y; Zhang R; Liu C; Wei Y; Sun J; He Z; Xu Y; Zhang T
Drug Deliv Transl Res; 2018 Oct; 8(5):1335-1344. PubMed ID: 29777509
[TBL] [Abstract][Full Text] [Related]
12. A carbamate-based approach to primaquine prodrugs: antimalarial activity, chemical stability and enzymatic activation.
Mata G; do Rosário VE; Iley J; Constantino L; Moreira R
Bioorg Med Chem; 2012 Jan; 20(2):886-92. PubMed ID: 22189276
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA
J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560
[TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial activities of norfloxacin against clinical isolates from ocular infections].
Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Aug; 48(8):1009-25. PubMed ID: 7474324
[TBL] [Abstract][Full Text] [Related]
15. Factor VIIa inhibitors: a prodrug strategy to improve oral bioavailability.
Riggs JR; Kolesnikov A; Hendrix J; Young WB; Shrader WD; Vijaykumar D; Stephens R; Liu L; Pan L; Mordenti J; Green MJ; Sukbuntherng J
Bioorg Med Chem Lett; 2006 Apr; 16(8):2224-8. PubMed ID: 16458507
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of carbamate prodrugs of SQ109 as antituberculosis agents.
Meng Q; Luo H; Liu Y; Li W; Zhang W; Yao Q
Bioorg Med Chem Lett; 2009 May; 19(10):2808-10. PubMed ID: 19362471
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase.
Hay MP; Atwell GJ; Wilson WR; Pullen SM; Denny WA
J Med Chem; 2003 Jun; 46(12):2456-66. PubMed ID: 12773049
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of oxodioxolenylmethyl carbamate prodrugs of pseudomycins.
Sun X; Rodriguez M; Zeckner D; Sachs B; Current W; Boyer R; Paschal J; McMillian C; Chen SH
J Med Chem; 2001 Aug; 44(16):2671-4. PubMed ID: 11472220
[TBL] [Abstract][Full Text] [Related]
19. Phosphoryloxymethyl carbamates and carbonates--novel water-soluble prodrugs for amines and hindered alcohols.
Safadi M; Oliyai R; Stella VJ
Pharm Res; 1993 Sep; 10(9):1350-5. PubMed ID: 8234176
[TBL] [Abstract][Full Text] [Related]
20. Studies on prodrugs. 5. Synthesis and antimicrobial activity of N-(oxoalkyl)norfloxacin derivatives.
Kondo H; Sakamoto F; Kodera Y; Tsukamoto G
J Med Chem; 1986 Oct; 29(10):2020-4. PubMed ID: 3761321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
